Advanced mammography technology now available to Douglas residents

The best defense against breast cancer is early detection. Annual screening mammography provides patients with the best chance for detecting cancer in the earliest possible stages. Furthermore, 3D Mammography (also known as Tomosynthesis) is known to be one of the most advanced forms of diagnostic tests available for the screening of breast cancer, especially for women with dense breast tissue (which is 40% of women). This leading-edge technology is now being offered to patients in Douglas County through Carson Tahoe’s Minden Medical Center, located at 925 Ironwood Drive.

The 3D Tomosynthesis produces a high resolution picture of the breast which helps to decrease false positives while increasing a patient’s chance for early detection.

“Studies have shown that 3D mammography technology helps in detecting breast cancers that may be hidden from view in traditional mammograms,” said Michelle Joy, Vice President and Chief Operating Officer at Carson Tahoe Health. “Carson Tahoe is dedicated to educating and empowering women in our community to take charge of their health. This powerful tool will aid in detecting problems sooner and provide the best possible outcomes.”

Previously, women in the region needed to travel outside of the area for this type of diagnostic screening. In addition to providing the most in-depth, 3D images for the detection of breast cancer, this technology also significantly lowers call-back rates; eliminating unnecessary anxiety and inconvenience for women who would otherwise return for additional imaging.

Beginning early August, this state-of-the-art technology will also be available in Carson City at the new Carson Tahoe Breast Center. We recommend that patients check with their insurance providers to confirm coverage in advance of your screening.

To schedule an appointment for your next 3D mammogram, call (775) 445-5500. To learn more about the more about the new Carson Tahoe Breast Center, visit


Use the comment form below to begin a discussion about this content.

Sign in to comment